Which has the lower trailing P/E, MEDP or ZBH?

ZBH has the lower trailing P/E: MEDP trades at 35.80 and ZBH at 23.27. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MEDP or ZBH?

Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus ZBH at 2.89%.

Does MEDP or ZBH pay a bigger dividend?

ZBH pays a dividend (1.01% yield), while MEDP has no payments in the available dividend history.

Is MEDP or ZBH more profitable?

MEDP runs the higher net margin — MEDP at 17.67% versus ZBH at 9.48%.

How have MEDP and ZBH total returns compared?

Over the past 10 years, MEDP delivered 34.83% and ZBH delivered -1.67% annualized total return. Past performance doesn't predict future results.

Medpace Holdings, Inc. (MEDP) vs Zimmer Biomet Holdings, Inc. (ZBH)

A side-by-side comparison of Medpace Holdings, Inc. and Zimmer Biomet Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

MEDP

Medpace Holdings, Inc.

$17.06B

$611.14HealthcareDelayed quote: Sep 18, 2026, 2:15 PM EDT

ZBH

Zimmer Biomet Holdings, Inc.

$18.51B

$95.66HealthcareDelayed quote: Sep 18, 2026, 2:15 PM EDT

Total return — MEDP vs ZBH

growth of $100 · dividends reinvested · last 10y

MEDP +1870.8% (+34.7%/yr)ZBH -18.2% (-2.0%/yr)MEDP compounded faster over this window

Log scale — wide-divergence pair

MEDP ZBH

MEDP vs ZBH: by the numbers

•ZBH is the larger company ($18.51B vs $17.06B market cap).
•ZBH trades at the lower trailing earnings multiple (23.27 vs 35.80 P/E), one valuation lens rather than an overall verdict.
•MEDP converts more revenue to profit (17.67% vs 9.48% net margin).
•MEDP grew revenue faster over the past five years (22.03% vs 2.89% CAGR).
•ZBH pays a dividend (1.01% yield), while MEDP has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	MEDP	ZBH
P/E ratio	35.80	23.27
Forward P/E	34.72	11.21
P/S ratio	6.13	2.17
P/B ratio	39.32	1.47
EV / EBITDA	27.28	10.93
FCF yield	4.11%	6.88%

Profitability

Metric	MEDP	ZBH
Gross margin	28.76%	61.62%
Operating margin	20.97%	15.73%
Net margin	17.67%	9.48%
ROE	113.29%	6.39%
ROIC	77.00%	5.51%

Dividends

Metric	MEDP	ZBH
Dividend yield	N/A	1.01%
Payout ratio	N/A	23.36%

Growth (annualized)

Metric	MEDP	ZBH
Revenue CAGR (5Y)	22.03%	2.89%
EPS CAGR (5Y)	30.90%	N/A
FCF CAGR (5Y)	23.40%	6.49%
Total return CAGR (5Y)	25.09%	-6.74%

Frequently asked

Which has the lower trailing P/E, MEDP or ZBH?: ZBH has the lower trailing P/E: MEDP trades at 35.80 and ZBH at 23.27. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MEDP or ZBH?: Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus ZBH at 2.89%.
Does MEDP or ZBH pay a bigger dividend?: ZBH pays a dividend (1.01% yield), while MEDP has no payments in the available dividend history.
Is MEDP or ZBH more profitable?: MEDP runs the higher net margin — MEDP at 17.67% versus ZBH at 9.48%.
How have MEDP and ZBH total returns compared?: Over the past 10 years, MEDP delivered 34.83% and ZBH delivered -1.67% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MEDP analysis Full ZBH analysis Interactive comparison tool

Dig into the metrics

Medpace P/E ratio Zimmer Biomet P/E ratio Zimmer Biomet dividend yield Medpace ROE Zimmer Biomet ROE Medpace operating margin Zimmer Biomet operating margin Medpace revenue growth Zimmer Biomet revenue growth Medpace free cash flow Zimmer Biomet free cash flow

Medpace & Zimmer Biomet appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.